Clinical Trial: New Antibiotic to treat patients with community-acquired pneumonia due to a specific bacteria (S. pneumoniae pneumonia)

This study has been completed.

Sponsored by: Pfizer
Information provided by: Pfizer

Purpose

This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)

Condition Treatment or Intervention Phase
Pneumonia, Pneumococcal
Community Acquired Infections
Gram-Positive Bacterial Infections
 Drug: Antibiotic
Phase III

MedlinePlus related topics:  Bacterial Infections;   Pneumonia;   Streptococcal Infections;   Throat Disorders

Study Type: Interventional
Study Design: Treatment

Eligibility

Ages Eligible for Study:  13 Years and above,  Genders Eligible for Study:  Both

Criteria

Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary.

Inclusion Criteria:

  • Patients must have the signs and symptoms of pneumonia, with a chest xray showing a pneumonia.
  • The patient must have S. pneumoniae (a specific bacteria) growing in sputum or blood to continue treatment.

Exclusion Criteria:

  • Patients cannot have taken more than one day of another antibiotic before entering this study.
  • Patients with HIV and a low CD4 count are excluded.

Location Information


California
      Research Center, Los Angeles,  California,  90033,  United States

Florida
      Research Center, Naples,  Florida,  34102,  United States

      Research Center, Jacksonville,  Florida,  32209,  United States

Georgia
      Research Center, Savannah,  Georgia,  31416,  United States

Illinois
      Research Center, Springfield,  Illinois,  62701,  United States

Louisiana
      Research Center, Baton Rouge,  Louisiana,  70808,  United States

Maryland
      Research Center, Baltimore,  Maryland,  21201,  United States

Michigan
      Research Center, Ann Arbor,  Michigan,  48197,  United States

      Research Center, Royal Oak,  Michigan,  48073,  United States

Missouri
      Research Center, Springfield,  Missouri,  65807,  United States

New Jersey
      Research Center, Hackensack,  New Jersey,  07601,  United States

      Research Center, Somerville,  New Jersey,  08876,  United States

      Research Center, Newark,  New Jersey,  07102,  United States

New York
      Research Center, Staten Island,  New York,  10305,  United States

      Research Center, Stony Brook,  New York,  11794,  United States

Ohio
      Research Center, Columbus,  Ohio,  43215,  United States

      Research Center, Zanesville,  Ohio,  43701,  United States

Pennsylvania
      Research Center, Hershey,  Pennsylvania,  17033,  United States

      Research Center, Fleetwood,  Pennsylvania,  19522,  United States

South Carolina
      Research Center, Spartanburg,  South Carolina,  29307,  United States

      Research Center, Ninety Six,  South Carolina,  29666,  United States

Tennessee
      Research Center, Knoxville,  Tennessee,  37920,  United States

      Research Center, Harrogate,  Tennessee,  37752-0078,  United States

      Research Center, Nashville,  Tennessee,  37205,  United States

      Research Center, Memphis,  Tennessee,  38163,  United States

      Research Center, Memphis,  Tennessee,  38120,  United States

      Research Center, Jackson,  Tennessee,  38301,  United States

      Research Center, Memphis,  Tennessee,  38104-3499,  United States

Texas
      Research Center, Dallas,  Texas,  75235,  United States

      Research Center, Lubbock,  Texas,  79430,  United States

      Research Center, Houston,  Texas,  77030,  United States

Virginia
      Research Center, Charlottesville,  Virginia,  22902,  United States

      Research Center, Richmond,  Virginia,  23294,  United States

Washington
      Research Center, Seattle,  Washington,  98108,  United States

Slovakia
      Research Center, Bratislava,  Slovakia

Spain
      Research Center, Barcelona,  08036,  Spain

      Research Center, Barcelona,  08907,  Spain

      Research Center, Barcelona,  08025,  Spain

      Research Center, Girona,  17007,  Spain

      Research Center, Madrid,  28923,  Spain

      Research Center, Madrid,  28046,  Spain

      Research Center, Madrid,  28034,  Spain

Spain, Barcelona
      Research Center, Mataro,  Barcelona,  08304,  Spain

Spain, Madrid
      Research Center, Mostoles,  Madrid,  28935,  Spain

Taiwan, Province of China
      Research Center, Taoyuan,  Taiwan, Province of China

      Research Center, Kaohsiung,  Taiwan, Province of China

More Information

Study ID Numbers:  M/1260/0071
Record last reviewed:  March 2004
Last Updated:  October 13, 2004
Record first received:  May 2, 2002
ClinicalTrials.gov Identifier:  NCT00035269
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources